Biological and Pharmaceutical Bulletin p. 1199 - 1203 (1997)
Update date:2022-08-29
Topics:
Muramatsu, Shigeki
Komokata, Yuko
Tanaka, Yorihisa
Takahagi, Hidekuni
When incubated with isolated rat hepatocytes, pravastatin sodium (PS) yielded a small amount of a metabolite in addition to two major metabolites that have already been reported. The previously uncharacterized metabolite was found to be formed by at first being enzymatically dehydrogenated to 6'- keto intermediate (R-104), followed by decomposition to give the aromatized metabolite (R-195), through spontaneous deesterification with accompanying aromatization. The PS-6'β-hydroxydehydrogenase activity was localized in cytosolic fraction and required NADP, preferentially over NAD, as a cofactor. The formation of R-195 by rat liver cytosol was strongly inhibited by indomethacin, 3α-hydroxysteroids (but not 3β-isomers) and 3-ketosteroids. The results and high substrate specificity of purified PS-6'β- hydroxydehydrogenase toward 3α-hydroxysteroids suggested that the enzyme is identical to 3α-hydroxysteroid dehydrogenase.
View MoreContact:(1) 206-3550089
Address:5115 NE 8TH PL, Renton, WA 98059 USA
Xiamen Goodhealth Pharmchem Co., Ltd.
Contact:0086-592-2097683
Address:404R No.2 54# Minzu Rd., Xiamen, China
Qingdao Kylin Trading Co., Ltd.
Contact:0086-532-68979884/58972912/68972263/65/88171519
Address:Room 2308,A building International Trade Center No.230 Changjiang Middle Road of Qingdao Economic Development Zone,Shandong,China.
Shanghai KFSL Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-39971718
Address:859 jiadingchengliu shanghai
Puyang Ruicheng Chemical Co.,Ltd
Contact:+86-18939306526
Address:No. 285 Renmin Road,Puyang City
Doi:10.1007/s10562-019-02811-w
(2019)Doi:10.1246/bcsj.58.393
(1985)Doi:10.1016/j.crci.2015.05.019
(2015)Doi:10.1021/ic500086k
(2014)Doi:10.3987/COM-07-S(U)45
(2007)Doi:10.1039/a708183i
(1998)